Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - TOTAL CURRENT LIABILITIES
Total Current Liabilities RARE - Ultragenyx Pharmaceutical Inc.
280 M
LAST VALUE
24.35%
2 YEAR CAGR
30.28%
5 YEAR CAGR
47.08%
10 YEAR CAGR